Resverlogix and EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19 in the United States and Canada CALGARY, AB and CHICAGO — June 3, 2021 — Resverlogix Corp. ("Resverlogix") (TSX:RVX) and EVERSANA™, the pioneer of next.